-transparent.png){kind=logo}
By using an assay system based on a human hepatoblastoma cell line (HB611) that continuously synthesizes hepatitis B virus DNA, the following compounds were found to inhibit hepatitis B virus DNA synthesis at concentrations that were significantly lower than their minimum cytotoxic concentrations: 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP), (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine, 9-(phosphonylmethoxyethyl)adenine, 2',3'-dideoxy-2',3'-didehydrocytidine, and 2',3'-dideoxycytidine. The most potent compound was PMEDAP (50% effective concentration, 0.02 micrograms/ml). The selective index, or ratio of the 50% cytotoxic concentration to 50% effective concentration, of PMEDAP was greater than 750.
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
March 1986,
The Tohoku journal of experimental medicine,
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
September 1989,
Antiviral research,
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
March 1997,
The Journal of general virology,
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
June 1990,
Journal of medical virology,
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
August 1987,
Antimicrobial agents and chemotherapy,
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
September 1994,
Antimicrobial agents and chemotherapy,
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
January 1990,
Antiviral research,
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
March 2014,
Phytochemistry,
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
October 2022,
International journal of molecular sciences,
T Yokota, and
S Mochizuki, and
K Konno, and
S Mori, and
S Shigeta, and
E De Clercq
January 1996,
Microbiology and immunology,
